Home / NYT / CureVac’s vaccine performed poorly in a clinical trial, in part because of virus variants.

CureVac’s vaccine performed poorly in a clinical trial, in part because of virus variants.

Virual stuff June 16, 2021 NYT

By BY CARL ZIMMER from NYT Health https://ift.tt/2S3JZhJ

CureVac’s vaccine performed poorly in a clinical trial, in part because of virus variants.

CureVac’s vaccine performed poorly in a clinical trial, in part because of virus variants.

Reviewed by Virual stuff on June 16, 2021 Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )